Actualités

Communiqué de Presse

Financial Press Release | Oncodesign
Communiqué de Presse
06/10/2020

Oncodesign obtains €15.9 million of non-dilutive financing in the form of a State-Guaranteed Loan within the context of the COVID-19 pandemic

Lire la suite
Financial Press Release | Oncodesign
Communiqué de Presse
10/09/2020

Oncodesign announces a capital increase reserved for the Company’s Management Committee

Lire la suite
Financial Press Release | Oncodesign
Communiqué de Presse
20/05/2020

Oncodesign and HitGen announce a strategic partnership in Integrated Drug Discovery Services (IDDS)

Lire la suite
Financial Press Release | Oncodesign
Communiqué de Presse
20/04/2020

Oncodesign announces the creation of its new “Artificial Intelligence” Business Unit and appoints Stéphane Gerart as its Head

Lire la suite
Financial Press Release | Oncodesign
Communiqué de Presse
17/02/2020

Oncodesign and Servier reach a key first milestone in their strategic partnership on LRRK2 inhibitors for Parkinson’s Disease

Lire la suite
Financial Press Release | Oncodesign
Communiqué de Presse
17/12/2019

Oncodesign announces the selection of its First-in-Class RIPK2 inhibitor drug candidate for auto-immune and inflammatory diseases

Lire la suite
Financial Press Release | Oncodesign
Communiqué de Presse
24/10/2019

Oncodesign: publication of an article presenting promising results for the treatment of stone man syndrome (FOP)

Lire la suite
Financial Press Release | Oncodesign
Communiqué de Presse
25/06/2019

Oncodesign reaches a key milestone in the development of its RIPK2 program

Lire la suite
Financial Press Release | Oncodesign
Communiqué de Presse
11/03/2019

Parkinson’s disease: Servier and Oncodesign join forces to investigate new line of research

Lire la suite
Financial Press Release | Oncodesign
Communiqué de Presse
07/11/2018

Service partnership agreement between Oncodesign and Galderma

Press Release: Multi-year service contract: design and discover new drug candidates in dermatology - Galderma.

Lire la suite
Financial Press Release | Oncodesign
Communiqué de Presse
15/10/2018

Centre Georges François Leclerc Presents the Detailed Results of the First Two Stages of its Clinical Study in Lung Cancer at the EANM Congress

Presentation of detailed results from the first two stages of the clinical trial in lung cancer | 31st EANM1 | 2018.

Lire la suite
Financial Press Release | Oncodesign
Communiqué de Presse
18/09/2018

Precision medicine: Cap Digital and Medicen Paris-Region team-up with Oncodesign, Servier and Intersystems on Hu-PreciMED

Hu-PreciMED project will gear French precision medicine industry towards discovering new diagnostic approaches & novel therapeutic treatments.

Lire la suite